Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice

Young Mi Kim, Zhikun Ma, Seungjik Lee, Ji-Yun Lee, Shibo Li, Xiaohe Yang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

erbB-2 is amplified or overexpressed in approximately 30% of human breast cancers, and has been associated with poor prognosis and therapeutic resistance. Previous studies have suggested that erbB-2 overexpression in transgenic mice induces genomic instability; however, the patterns of genetic lesions vary with individual model systems. The development of mammary tumors in multiparous murine mammary tumor virus (MMTV)-erbB-2 transgenic mice is accelerated due to hormonal interactions which induce the overexpression of MMTV--mediated erbB-2. However, whether or not accelerated tumor development is associated with modified cytogenetic patterns remains to be determined. In this study, chromosomal changes were characterized in mammary tumor cells derived from multiparous MMTV-erbB-2 transgenic mice, and compared with tumor cells derived from control virgin mice. Immunohistochemistry and Western blotting were used to detect erbB-2 overexpression in mammary tissues. Each of the five tumors from the multiparous MMTV-erbB-2 transgenic mice was found to exhibit a marked chromosomal imbalance, compared with only one tumor with aberrant chromosomes among the five tumors from the control virgin mice. In particular, trisomy 5 and loss of the X chromosome were recurrent cytogenetic lesions in tumors from the parous mice, which is a novel pattern compared with previous studies. The elevated number of genetic lesions in tumors from parous mice, which were characterized by enhanced erbB-2 overexpression and increased receptor tyrosine kinase activation in the mammary glands, suggest a causal role for erbB-2 in the genomic instability present in these tumors. These data advance our understanding of erbB-2-mediated pathogenesis and underscore the role of cytogenetic alteration in this process.

Original languageEnglish
Pages (from-to)1077-1081
Number of pages5
JournalOncology Letters
Volume2
Issue number6
DOIs
Publication statusPublished - 2011 Nov 1
Externally publishedYes

Fingerprint

Gammaretrovirus
Chromosomes, Human, Pair 5
Trisomy
Cytogenetics
Transgenic Mice
Breast Neoplasms
Neoplasms
Genomic Instability
Receptor Protein-Tyrosine Kinases
X Chromosome
Human Mammary Glands
Breast
Chromosomes
Western Blotting
Immunohistochemistry

Keywords

  • Breast cancer
  • erbB-2/Neu
  • Genomic instability
  • Transgenic mouse model

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. / Kim, Young Mi; Ma, Zhikun; Lee, Seungjik; Lee, Ji-Yun; Li, Shibo; Yang, Xiaohe.

In: Oncology Letters, Vol. 2, No. 6, 01.11.2011, p. 1077-1081.

Research output: Contribution to journalArticle

Kim, Young Mi ; Ma, Zhikun ; Lee, Seungjik ; Lee, Ji-Yun ; Li, Shibo ; Yang, Xiaohe. / Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. In: Oncology Letters. 2011 ; Vol. 2, No. 6. pp. 1077-1081.
@article{513f3ac2d9d049cc9171929ca0bfd6b5,
title = "Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice",
abstract = "erbB-2 is amplified or overexpressed in approximately 30{\%} of human breast cancers, and has been associated with poor prognosis and therapeutic resistance. Previous studies have suggested that erbB-2 overexpression in transgenic mice induces genomic instability; however, the patterns of genetic lesions vary with individual model systems. The development of mammary tumors in multiparous murine mammary tumor virus (MMTV)-erbB-2 transgenic mice is accelerated due to hormonal interactions which induce the overexpression of MMTV--mediated erbB-2. However, whether or not accelerated tumor development is associated with modified cytogenetic patterns remains to be determined. In this study, chromosomal changes were characterized in mammary tumor cells derived from multiparous MMTV-erbB-2 transgenic mice, and compared with tumor cells derived from control virgin mice. Immunohistochemistry and Western blotting were used to detect erbB-2 overexpression in mammary tissues. Each of the five tumors from the multiparous MMTV-erbB-2 transgenic mice was found to exhibit a marked chromosomal imbalance, compared with only one tumor with aberrant chromosomes among the five tumors from the control virgin mice. In particular, trisomy 5 and loss of the X chromosome were recurrent cytogenetic lesions in tumors from the parous mice, which is a novel pattern compared with previous studies. The elevated number of genetic lesions in tumors from parous mice, which were characterized by enhanced erbB-2 overexpression and increased receptor tyrosine kinase activation in the mammary glands, suggest a causal role for erbB-2 in the genomic instability present in these tumors. These data advance our understanding of erbB-2-mediated pathogenesis and underscore the role of cytogenetic alteration in this process.",
keywords = "Breast cancer, erbB-2/Neu, Genomic instability, Transgenic mouse model",
author = "Kim, {Young Mi} and Zhikun Ma and Seungjik Lee and Ji-Yun Lee and Shibo Li and Xiaohe Yang",
year = "2011",
month = "11",
day = "1",
doi = "10.3892/ol.2011.373",
language = "English",
volume = "2",
pages = "1077--1081",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice

AU - Kim, Young Mi

AU - Ma, Zhikun

AU - Lee, Seungjik

AU - Lee, Ji-Yun

AU - Li, Shibo

AU - Yang, Xiaohe

PY - 2011/11/1

Y1 - 2011/11/1

N2 - erbB-2 is amplified or overexpressed in approximately 30% of human breast cancers, and has been associated with poor prognosis and therapeutic resistance. Previous studies have suggested that erbB-2 overexpression in transgenic mice induces genomic instability; however, the patterns of genetic lesions vary with individual model systems. The development of mammary tumors in multiparous murine mammary tumor virus (MMTV)-erbB-2 transgenic mice is accelerated due to hormonal interactions which induce the overexpression of MMTV--mediated erbB-2. However, whether or not accelerated tumor development is associated with modified cytogenetic patterns remains to be determined. In this study, chromosomal changes were characterized in mammary tumor cells derived from multiparous MMTV-erbB-2 transgenic mice, and compared with tumor cells derived from control virgin mice. Immunohistochemistry and Western blotting were used to detect erbB-2 overexpression in mammary tissues. Each of the five tumors from the multiparous MMTV-erbB-2 transgenic mice was found to exhibit a marked chromosomal imbalance, compared with only one tumor with aberrant chromosomes among the five tumors from the control virgin mice. In particular, trisomy 5 and loss of the X chromosome were recurrent cytogenetic lesions in tumors from the parous mice, which is a novel pattern compared with previous studies. The elevated number of genetic lesions in tumors from parous mice, which were characterized by enhanced erbB-2 overexpression and increased receptor tyrosine kinase activation in the mammary glands, suggest a causal role for erbB-2 in the genomic instability present in these tumors. These data advance our understanding of erbB-2-mediated pathogenesis and underscore the role of cytogenetic alteration in this process.

AB - erbB-2 is amplified or overexpressed in approximately 30% of human breast cancers, and has been associated with poor prognosis and therapeutic resistance. Previous studies have suggested that erbB-2 overexpression in transgenic mice induces genomic instability; however, the patterns of genetic lesions vary with individual model systems. The development of mammary tumors in multiparous murine mammary tumor virus (MMTV)-erbB-2 transgenic mice is accelerated due to hormonal interactions which induce the overexpression of MMTV--mediated erbB-2. However, whether or not accelerated tumor development is associated with modified cytogenetic patterns remains to be determined. In this study, chromosomal changes were characterized in mammary tumor cells derived from multiparous MMTV-erbB-2 transgenic mice, and compared with tumor cells derived from control virgin mice. Immunohistochemistry and Western blotting were used to detect erbB-2 overexpression in mammary tissues. Each of the five tumors from the multiparous MMTV-erbB-2 transgenic mice was found to exhibit a marked chromosomal imbalance, compared with only one tumor with aberrant chromosomes among the five tumors from the control virgin mice. In particular, trisomy 5 and loss of the X chromosome were recurrent cytogenetic lesions in tumors from the parous mice, which is a novel pattern compared with previous studies. The elevated number of genetic lesions in tumors from parous mice, which were characterized by enhanced erbB-2 overexpression and increased receptor tyrosine kinase activation in the mammary glands, suggest a causal role for erbB-2 in the genomic instability present in these tumors. These data advance our understanding of erbB-2-mediated pathogenesis and underscore the role of cytogenetic alteration in this process.

KW - Breast cancer

KW - erbB-2/Neu

KW - Genomic instability

KW - Transgenic mouse model

UR - http://www.scopus.com/inward/record.url?scp=80052763558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052763558&partnerID=8YFLogxK

U2 - 10.3892/ol.2011.373

DO - 10.3892/ol.2011.373

M3 - Article

VL - 2

SP - 1077

EP - 1081

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 6

ER -